MerTK/Axl-IN-1
MerTK/Axl-IN-1 (Compound A-910) is a potent and selective dual MerTK/Axl inhibitor, with IC50s of 4.2 and 8.8 nM in Ba/F3, and 0.2 and 0.9 nM in HTRF. MerTK/Axl-IN-1 results in pMerTK inhibition in vivo. MerTK/Axl-IN-1 has long half-life, high oral exposure and bioavailability[1].
Product Specifications
CAS Number
3036009-40-9
UNSPSC
12352005
Target
TAM Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mertk-axl-in-1.html
Smiles
FC1=NC=CC=C1C2=CC(C(N[C@H]3CCC[C@@H]3OCC4=CC=C(C5=CC(CCC[C@@H]6N7CCN(C[C@@H](CO)O)CC7)=C6C=C5)C=C4)=O)=C(N)N=C2
Molecular Formula
C40H47FN6O4
Molecular Weight
694.84
References & Citations
[1]Yu Y, et al. Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor. J Med Chem. 2024 Sep 16.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA397893 500 µg
Mouse IgG2b Antibody ATTO 655 Conjugated Pre-adsorbed
Sign In for Pricing
View Details 
BNC472172-100 1x 100 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (rEGP40/1372), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details